CD68 immunostaining revealed macrophage aggregation constituting hCLS in the liver from NAFLD/NASH patients (Figure 4A, 4B, and 4D), which was rarely observed in patients with chronic viral hepatitis (Figure 4C and 4D). Here, CD68 is linked to metabolic dysfunction-associated steatotic liver disease.